MSM® STENTS 2017

from MSM® – a German company
which specializes in medical devices.
MSM® stents have CE approval
and are ISO 9001 certified.
all products are Made in Germany!

MSM® DES Sirolimus

SAFETY – EFFICACY – DELIVERABILITY

MSM DES Sirolimus 1

The MSM Sirolimus Eluting Coronary Stent System convinces with its trusted Cobalt Chromium Platform and the largest size portfolio available.

A fully biodegradable polymer coating containing Sirolimus (Rapamycin), enables controlled drug release preventing early thrombotic events and stent restenosis.

The biocompatible PLGA Polymer provides consistent, controlled and a 100 % drug release. The Polymer degrades 100 % into carbon dioxide and water.

The decreased profile results in an increased flexibility and enables an easy side branch access.

 

MSM DES Sirolimus 2

 

      Safety and Efficiency of Sirolimus

Effective Factor – Drug

Acting on G1 phase or M phase has different effects

MSM DES Sirolimus 4

 

Polymer Coating of MSM Sirolimus
PLGA 85/15 Biocompatible Polymer

MSM DES Sirolimus 5
The thickness of biodegradable polymer-coating is only 5 μm, thinner coating increases the ability and effectiveness of delivery.

   

  Advanced Coating Technology

MSM DES Sirolimus 6
During the age of DES, it is very important for stent to remain uniform and smooth after deployment.

    Advanced Surface treatment & Coating Technology

During expansion

MSM DES Sirolimus 7
Unique technology for the metal surface treatment, and advanced spraying procedure

After expansion

MSM DES Sirolimus 8
Great anti-deformability Coating uniform No collapse

 

Factor that affects efficacy Polymer Coating

 drug releasing pattern would affect the whole process of restenosis       
MSM DES Sirolimus 9

Four courses of intimal repairing can cause restenosis

  • Platelet deposition occurring in 15 days after stent implantation
  • Leukocyte recruitment occurring in 50 days
  • SMC migration/proliferation occurring in 90 days
  • Matrix deposition occurring after 120 days

 

Drug Release Rate

MSM DES Sirolimus 10

 

90-days drug releasing time First 80% of drug dosage can be released in first month. This controlled drug releasing rate can effectively prevent restenosis during intimal repairing progress

 

MSM Sirolimus Stent Design

MSM DES Sirolimus 11
Double-helix lengthways structure shape provides excellent deliverability and conformability

 

 

 

 

 

MSM DES Sirolimus 12
Sine wave design of horizontal structure provide uniform scaffolding and excellent support force

 

Well-balanced Support and Deliverability

Material Cobalt Chromium
Strut thickness 65 μm
Coating thickness 3 – 5 μm
Metal-artery ratio 15% – 18%
Balloon tip profile 0.017″ (0.43mm)
Lowest crossing profile 0.035″ (0.90mm)
Recoil >2%

A lot of published papers* showed that the use of a thinner strut stent is associated with a significant reduction of angiographic and clinical restenosis after coronary artery stenting.

* “Intracoronary Stenting and Angiographic Results – Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial” , Adnan Kastraiti MD, Albert Schömig MD, 2001; 103:2816-2821, Circulation

* “In-Stent Restenosis in Small Coronary Arteries – Impact of Strut Thickness” , Carlo Briguori MD etc., Vol. 40, No. 3, 2002, Journal of the American College of Cardiology

 

MSM DES Sirolimus

– Excellent Side Branch Access

MSM DES Sirolimus 13

open cell design with 3 interlinks per segment
Diameter of mostly used device

MSM DES Sirolimus 14
  • Guidewire: BMW 0.014” (0.36mm)
  • Balloon Dilation Catheter: 0.024” (0.61mm)

 

Delivery system of MSM DES Sirolimus

MSM DES Sirolimus 15
Nominal inflation pressure is 8 atm

  • Hydrophilic coated distal shaft 1.9F shaft with a rapid deflation balloon
  • The balloon design optimizes a controlled linear expansion
  • A balloon overhang of <5 mm minimises vessel injury outside the stent

Technical Details Stent

Type of design open cell design with 3 interlinks per segment
Design details 9 crown per segment
Material Cobalt-Chromium L605
Size Range 2.25 mm – 4.00 mm
Strut thickness 0.0026″ ( 65μm )
Strut width (Main segment) 0.0028″ ( 72μm )
Strut width (interlink) 0.0023″ ( 58μm )
Shortening after expansion < 2%
Recoil < 5%
Sirolimus Matrix Thickness < 18%
3-5 μm
Guinding Catheter compatibility 5 F

Technical Details Catheter

Usable length 138 cm
Length of the guide wire lumen 27 cm
Material Balloon
Distal shaft Polyamide, Multi layer tubing
Proximal shaft Stainless Steel with PTFE Coating
Shaft size Proximal
Distal 2.5 F – 2.9 F, depending on balloon size
Balloon folding Balloon sizes 2.25 mm bis 2.5 mm
Balloon sizes 2.75 mm to 4.50 mm 4-fold balloon
Marker Embedded Platinum/ Iridium Marker
Tip profile 0.017″ (0.43 mm)
Max. recommended guide wire 0.014″ (0.36 mm)

Specifications of MSM DES Sirolimus

MSM DES Sirolimus 16
43 and 48 mm long stent, saving for both patients and doctors

Compliance Data

MSM DES Sirolimus 17

Order Information

MSM DES Sirolimus 18